BLUEBIRD BIO, INCBLUEBIRD BIO, INCBLUEBIRD BIO, INC

BLUEBIRD BIO, INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−7.31MXN
Revenue estimate
‪319.24 M‬MXN
Market capitalization
‪2.93 B‬MXN
−12.96MXN
‪501.06 M‬MXN
‪189.83 M‬
Beta (1Y)
1.84

About bluebird bio, Inc.

CEO
Andrew Obenshain
Headquarters
Somerville
Founded
1992
FIGI
BBG00PG37XY3
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BLUE is 15.90 MXN — it has decreased by 23.37% in the past 24 hours. Watch BLUEBIRD BIO, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BLUEBIRD BIO, INC stocks are traded under the ticker BLUE.
BLUEBIRD BIO, INC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
BLUE stock is 31.08% volatile and has beta coefficient of 1.84. Track BLUEBIRD BIO, INC stock price on the chart and check out the list of the most volatile stocks — is BLUEBIRD BIO, INC there?
BLUE earnings for the last quarter are −11.50 MXN per share, whereas the estimation was −11.65 MXN resulting in a 1.29% surprise. The estimated earnings for the next quarter are −11.15 MXN per share. See more details about BLUEBIRD BIO, INC earnings.
BLUEBIRD BIO, INC revenue for the last quarter amounts to ‪216.00 M‬ MXN despite the estimated figure of ‪236.37 M‬ MXN. In the next quarter revenue is expected to reach ‪285.07 M‬ MXN.
Yes, you can track BLUEBIRD BIO, INC financials in yearly and quarterly reports right on TradingView.
BLUE stock has fallen by 21.75% compared to the previous week, the month change is a 21.75% fall, over the last year BLUEBIRD BIO, INC has showed a 21.75% decrease.
BLUE net income for the last quarter is ‪−1.25 B‬ MXN, while the quarter before that showed ‪−1.25 B‬ MXN of net income which accounts for −0.05% change. Track more BLUEBIRD BIO, INC financial stats to get the full picture.
Today BLUEBIRD BIO, INC has the market capitalization of ‪2.98 B‬, it has decreased by 3.32% over the last week.
No, BLUE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BLUE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLUEBIRD BIO, INC stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on BLUEBIRD BIO, INC future price: according to them, BLUE price has a max estimate of 136.04 MXN and a min estimate of 17.00 MXN. Watch BLUE chart and read a more detailed BLUEBIRD BIO, INC stock forecast: see what analysts think of BLUEBIRD BIO, INC and suggest that you do with its stocks.